Status:
UNKNOWN
The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The aim of this study is to evaluate the insulin-like growth factor (IGF) axis involvement in the immune tumor microenvironment in ovarian cancer.
Eligibility Criteria
Inclusion
- Women diagnosed with epithelium ovarian cancer who have undergone surgery
Exclusion
- Pregnant women
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03846856
Start Date
April 1 2019
End Date
March 1 2021
Last Update
April 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100